A detailed history of Annex Advisory Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Annex Advisory Services, LLC holds 4,221 shares of LLY stock, worth $3.36 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
4,221
Previous 4,403 4.13%
Holding current value
$3.36 Million
Previous $3.99 Million 6.2%
% of portfolio
0.14%
Previous 0.15%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$772.14 - $960.02 $140,529 - $174,723
-182 Reduced 4.13%
4,221 $3.74 Million
Q2 2024

Jul 12, 2024

BUY
$724.87 - $909.04 $51,465 - $64,541
71 Added 1.64%
4,403 $3.99 Million
Q1 2024

Apr 12, 2024

BUY
$592.2 - $792.28 $316,827 - $423,869
535 Added 14.09%
4,332 $3.37 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $812,468 - $957,794
1,547 Added 68.76%
3,797 $2.21 Million
Q3 2023

Oct 31, 2023

BUY
$434.7 - $599.3 $5,216 - $7,191
12 Added 0.54%
2,250 $1.21 Million
Q2 2023

Jul 24, 2023

SELL
$350.74 - $468.98 $4,208 - $5,627
-12 Reduced 0.53%
2,238 $1.05 Million
Q1 2023

Apr 27, 2023

SELL
$310.63 - $364.82 $2,485 - $2,918
-8 Reduced 0.35%
2,250 $772,000
Q4 2022

Jan 27, 2023

SELL
$321.55 - $374.67 $213,830 - $249,155
-665 Reduced 22.75%
2,258 $826,000
Q3 2022

Oct 24, 2022

BUY
$296.48 - $337.87 $2,075 - $2,365
7 Added 0.24%
2,923 $945,000
Q2 2022

Jul 27, 2022

BUY
$278.73 - $327.27 $142,988 - $167,889
513 Added 21.35%
2,916 $946,000
Q1 2022

Apr 13, 2022

BUY
$234.69 - $291.66 $19,244 - $23,916
82 Added 3.53%
2,403 $688,000
Q4 2021

Jan 31, 2022

BUY
$224.85 - $279.04 $99,833 - $123,893
444 Added 23.65%
2,321 $641,000
Q3 2021

Oct 18, 2021

SELL
$221.6 - $272.71 $71,133 - $87,539
-321 Reduced 14.6%
1,877 $434,000
Q2 2021

Jul 29, 2021

BUY
$180.55 - $233.54 $13,180 - $17,048
73 Added 3.44%
2,198 $504,000
Q1 2021

Apr 22, 2021

BUY
$164.32 - $212.72 $4,436 - $5,743
27 Added 1.29%
2,125 $397,000
Q4 2020

Jan 28, 2021

BUY
$130.46 - $172.63 $2,087 - $2,762
16 Added 0.77%
2,098 $354,000
Q3 2020

Oct 23, 2020

BUY
$146.22 - $169.13 $438 - $507
3 Added 0.14%
2,082 $308,000
Q2 2020

Jul 21, 2020

BUY
$136.42 - $164.18 $272 - $328
2 Added 0.1%
2,079 $341,000
Q1 2020

Apr 22, 2020

BUY
$119.05 - $147.35 $2,142 - $2,652
18 Added 0.87%
2,077 $288,000
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $3.4 Million - $4.21 Million
-31,825 Reduced 93.92%
2,059 $271,000
Q4 2019

Feb 10, 2020

BUY
$106.92 - $132.43 $3.4 Million - $4.21 Million
31,768 Added 1501.32%
33,884 $483,000
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $225,967 - $245,794
2,116 New
2,116 $236,000
Q2 2019

Jul 18, 2019

SELL
$110.79 - $129.32 $171,281 - $199,928
-1,546 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $172,085 - $202,556
1,546 New
1,546 $201,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Annex Advisory Services, LLC Portfolio

Follow Annex Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annex Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annex Advisory Services, LLC with notifications on news.